Archive · 31 Jan 2026
Q3 Results: Sun Pharma, GAIL India, and More
Several companies in India, including Sun Pharma and GAIL India, announced their results for the third quarter of the fiscal year 2025-26.
One of the companies reported a profit of Rs 7.03 crore, which is a big improvement from a loss of Rs 3.88 crore in the same period last year.
Their revenue increased by 38.6%, reaching Rs 60 crore.
The total expenses for the quarter were Rs 52.46 crore, and the cost for employees was ₹19.46 crore.
These results show that the company is doing better financially compared to the previous year.
Sun Pharma, GAIL India, and other companies announced their Q3 results on 31st January.
One company reported a profit after tax of Rs 7.03 crore, up from a loss of Rs 3.88 crore in the previous year.
Revenue from operations increased by 38.6% to Rs 60 crore in Q3 FY26 compared to Rs 43.29 crore in Q3 FY25.
Total expenditure for the quarter was Rs 52.46 crore, with employee costs amounting to ₹19.46 crore.
The results indicate a significant improvement in financial performance for the reporting company.
- Who
- Sun Pharma, GAIL India, IDFC First Bank, Birla Corporation, Zen Technologies, Bharat Dynamics, Delhivery, Fujiyama Power Systems
- What
- Announcement of Q3 results
- When
- 31st January
- Where
- India
- Why
- To report financial performance for the quarter
- Company
- Sun Pharma, GAIL India, IDFC First Bank, Birla Corporation, Zen Technologies, Bharat Dynamics, Delhivery, Fujiyama Power Systems
- Profit after tax
- Rs 7.03 crore
- Previous year loss
- Rs 3.88 crore
- Revenue increase
- 38.6%
- Q3 Revenue
- Rs 60 crore
- Previous Q3 Revenue
- Rs 43.29 crore
- Total expenditure
- Rs 52.46 crore
- Employee costs
- ₹19.46 crore